Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$0.00
$0.16
$1.57
$763K4.024,068 shsN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.61
$4.04
$2.82
$5.92
$59.43M1.1986,483 shs44,638 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00%0.00%0.00%0.00%-53.85%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+17.21%-19.60%-6.48%-25.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$0.00
$0.16
$1.57
$763K4.024,068 shsN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.61
$4.04
$2.82
$5.92
$59.43M1.1986,483 shs44,638 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00%0.00%0.00%0.00%-53.85%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+17.21%-19.60%-6.48%-25.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.57
Moderate Buy$6.8890.44% Upside

Current Analyst Ratings Breakdown

Latest SRTS and ARTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingBuy
4/21/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingSell (D)
3/6/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Initiated CoverageBuy$7.50
2/17/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lower Price TargetBuy$8.00 ➝ $6.00
(Data available from 5/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
$80K0.00N/AN/A($2.43) per share0.00
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$27.48M2.16N/AN/A$2.77 per share1.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
-$6.98M-$2.34N/AN/AN/A-8,257.70%N/A-730.22%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.47N/AN/AN/A-34.50%-15.79%-14.02%N/A

Latest SRTS and ARTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250-$0.16-$0.0350-$0.16$5.32 million$3.39 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
N/A
0.10
0.01
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
7.27
6.31

Institutional Ownership

CompanyInstitutional Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
6.91%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
4.50%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arch Therapeutics, Inc. stock logo
ARTH
Arch Therapeutics
104.74 million4.53 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.46 million14.78 millionOptionable

Recent News About These Companies

Sensus Healthcare Q1 Earnings Call Highlights
Sensus (SRTS) Q1 2026 Earnings Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Arch Therapeutics stock logo

Arch Therapeutics OTCMKTS:ARTH

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.61 0.00 (0.00%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$3.75 +0.14 (+3.85%)
As of 05/15/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.